Clinical trial
A Study to Evaluate the Pharmacokinetics of Meropenem and Piperacillin in Patients With Sepsis
NCT05807217 is registered in ClinicalTrials.gov with Shen Ning as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Pharmacokinetics of Meropenem and Piperacillin in Patients With Sepsis
- Lead sponsor
- Shen Ning
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 26, 2022
- Completion date
- December 31, 2023
- Enrollment
- 44 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.